Drug Profile
BX 1000
Alternative Names: BX-1000; RP 1000Latest Information Update: 13 Jun 2023
Price :
$50
*
At a glance
- Originator Cornell University
- Developer Baudax Bio; Cornell University
- Class Anaesthetics
- Mechanism of Action Neuromuscular blocking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Anaesthesia